Allogene Therapeutics, Inc. (ALLO)
Q4 2019 Earnings Conference Call
February 27, 2020 8:30 AM ET
Company Participants
Christine Cassiano – Chief Communications Officer
David Chang – President and Chief Executive Officer
Raphael Amado – Executive Vice President of Research and Development and Chief Medical Officer
Eric Schmidt – Chief Financial Officer
Conference Call Participants
Marc Frahm – Cowen and Company
Salveen Richter – Goldman Sachs
Biren Amin – Jefferies
Tyler Van Buren – Piper Sandler
Mark Breidenbach – Oppenheimer
John Newman – Canaccord
Reni Benjamin – JMP Securities
Presentation
Operator
Good morning, ladies and gentlemen,